RE: RNS - First order for SlimBiome in US!15 Apr 2025 07:46
OptiBiotix Health PLC
15 April 2025
OptiBiotix Health plc
("OptiBiotix" or the "Company" or "the Group")
First order from leading US weight management brand
OptiBiotix Health plc (AIM: OPTI), a life sciences business developing products which reduce hunger and food cravings, enhance the gut microbiome, and sweet fibres as healthy sugar substitutes, announces it has received its first order from a leading weight management brand in the United States of America ("USA").
The order is for SlimBiome® as an ingredient which will be incorporated into a range of flavoured drinks, similar to SlimBiome Medical, which reduces hunger. The products will be included in one of the USA's leading weight management brands. SlimBiome® has undergone multiple human studies which show its ability to reduce hunger and food cravings which leads to lower calorie intake. OptiBiotix has been working with this brand for over 18 months to carry out human studies which allows the brand to make health claims of hunger control on its products in the USA. Scientifically substantiated health claims help to differentiate these products from others on the market. In the changing landscape of this market, brought about by the anti-obesity drugs, consumers are actively looking for natural, science backed appetite support products. SlimBiome® meets this developing trend.
OptiBiotix expect further orders for a second product, a tablet containing SlimBiome®, within H1 2025. Whilst it is too early to understand the potential scale of the opportunity, this news is material in that it represents the inclusion of SlimBiome® in products of one of the USA's most popular weight management brands. Further information on the partner and brand will be announced on launch which the Company anticipates will be in H1 2025. However, the Company reminds investors that launch timescales are dictated by the brand owner and these can be subject to change.
Stephen O'Hara, CEO of OptiBiotix Health plc said: "Bla Bla Bla.